Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion type Assertion NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_head.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion description "[Significantly, pharmacological blockade of the ?(2A)AR by a clinically used antagonist reduces AD-related pathology and ameliorates cognitive deficits in an AD transgenic model, suggesting that repurposing clinical ?(2A)R antagonists would be an effective therapeutic strategy for AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion evidence source_evidence_literature NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion SIO_000772 25404298 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion wasDerivedFrom befree-2016 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.
- NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_assertion wasGeneratedBy ECO_0000203 NP1238094.RAOVcy9up7hGTf_Qm-kNzGSdoEDCe_VmBs-oMqMFWqYsc130_provenance.